Skip to main content
OpenTrials

Clinical trial condition

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Explore clinical trials studying Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis. Study availability and eligibility vary by location and protocol.

112 public trials 49 recruiting studies
Refine in advanced search Browse all conditions

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis trial results

Recruiting

Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders

NCT07089121

Conditions
ANCA-Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +19 more
Locations
  • H01- Children's National Hospital Washington D.C., District of Columbia, United States
  • H03- Washington University School of Medicine St Louis, Missouri, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details
Recruiting

A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis

NCT06072482

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Antineutrophil Cytoplasmic Antibody-associated Vasculitis, Autoimmune Diseases, +8 more
Locations
  • Orthopedic Physicians Alaska Anchorage, Alaska, United States
  • Scottsdale Healthcare at Shea - HonorHealth Scottsdale, Arizona, United States
  • Southwest Kidney Institute Surprise, Arizona, United States
  • Unity Health Searcy, Arkansas, United States
View all 83 locations
View Trial Details
Recruiting

A Trial to Evaluate the Efficacy of Pioglitazone to Promote Renal Tolerance in ANCA-associated Vasculitis - RENATO Trial

NCT05946564

Conditions
ANCA Associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +10 more
Locations
  • CHU Amiens Amiens, France
  • CHU d'Angers Angers, France
  • CH de Boulogne sur Mer Boulogne-sur-Mer, France
  • CHU Brest - Hôpital de la Cavale Blanche Brest, France
View all 25 locations
View Trial Details
Recruiting

Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis

NCT07160608

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Autoimmune Diseases, +8 more
Locations
  • Research Site Ciudad de Buenos Aires, Argentina
  • Research Site Ciudad de Buenos Aires, Argentina
  • Research Site La Plata, Argentina
  • Research Site Rosario, Argentina
View all 78 locations
View Trial Details

Related conditions